Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

Alessandro Giordano, Vittoria Rufini, Giorgio Treglia, Paola Castaldi, Chiara De Waure, Angelina Filice, Valentina Ambrosini, Nadia Cremonini, Annibale Versari, Stefano Fanti

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

To retrospectively evaluate and compare (18)F-FDG, (18)F-DOPA and (68)Ga-somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid carcinoma (MTC) suspected on the basis of elevated serum calcitonin levels.
Original languageEnglish
Pages (from-to)569-580
Number of pages12
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume39
DOIs
Publication statusPublished - 2012

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Calcitonin
  • Dihydroxyphenylalanine
  • Female
  • Fluorodeoxyglucose F18
  • Gallium Radioisotopes
  • Humans
  • Individualized Medicine
  • Male
  • Middle Aged
  • Positron-Emission Tomography and Computed Tomography
  • Recurrence
  • Retrospective Studies
  • Somatostatin
  • Thyroid Neoplasms

Fingerprint Dive into the research topics of 'Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma'. Together they form a unique fingerprint.

Cite this